Sjögren's disease & overlap diseases

Oscillometric, greyscale- and novel color-Doppler-ultrasound indices of macrovascular damage in Sjögren’s: the SICARD cohort study

Arthritis Res TherPublished Cross-sectional study

Authors' conclusion

In the largest cfPWV/US-cohort examined to date, pSS-patients had significantly higher aortic stiffness and atherosclerosis than controls. Aortic stiffness was predicted by systemic inflammation, alongside traditional CV risk factors.

Study context

Population
Patients with pSS and healthy controls (SICARD cohort)
Participants
119 vs 97
Exposure
pSS vs healthy controls
  • pSSn = 119
  • Controlsn = 97reference
Outcome
Oscillometric (cfPWV), greyscale- and color-Doppler US indices of carotid and aortic damage
Methodological detailscase-control comparison with healthy controls
  • Case-control comparison with healthy controls

Main finding

As reported in the abstract

Significantly higher cfPWV in patients vs controls
padj = 0.025
Significantly higher cIMT in patients vs controls
padj < 0.001
Significantly higher calcification area in patients vs controls
p = 0.013

Observational data: associations, not effects.

Further findings

Cardiovascular (CV) risk and subclinical damage in pSS

High CV risk by mSCORE
5.7%
Increased aortic stiffness by cfPWV
45.4%
Carotid atherosclerosis by carotid ultrasound (US)
69.2%

Correlates of cfPWV in pSS

Correlation with CRP, rho = 0.325
P < 0.001
Correlation with ESR, rho = 0.271
P = 0.003
Correlation with age, cholesterol, systolic blood pressure
all; p < 0.01

ICA-RI and ICA-PI in pSS with further (non-rheumatological) autoimmune diseases

ICA-RI and ICA-PI higher
both; p < 0.05

Original publication

Oscillometric, greyscale- and novel color-Doppler-ultrasound indices of macrovascular damage in Sjögren’s: the SICARD cohort study. Arthritis Res Ther. Published 1 August 2025. doi:10.1186/s13075-025-03625-5

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.